Login / Signup

Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART).

Jordana KronThomas CrawfordVirginia MihalickFrank BogunJennifer H JordanTodd KoellingHuzaefah SyedAamer SyedThomas IdenKelly PollyEmily FedermannKirsta BraySangeeta Lathkar-PradhanShilpa JastiLynda RosenfeldDavid BirnieMelissa SmallfieldLe KangAlpha Berry FowlerAmy LaddKenneth EllenbogenBenjamin Van TassellW Gregory HundleyAntonio Abbate
Published in: Journal of translational medicine (2021)
The current trial demonstrates an innovative collaborative approach to clinical trial development in a rare, understudied disease that disproportionately affects females and minorities. Trial Registration The trial was registered prospectively with ClinicalTrials.gov on July 12, 2019, identifier NCT04017936.
Keyphrases
  • clinical trial
  • phase iii
  • phase ii
  • study protocol
  • open label
  • left ventricular
  • randomized controlled trial
  • hiv infected
  • quality improvement
  • heart failure
  • antiretroviral therapy
  • placebo controlled